Výsledky vyhľadávania - "Brain Neoplasms/mortality [MeSH]"

TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progression

Autori: Wasilewski, David Araceli, Tommaso Bischoff, Philip a ďalší

Zdroj: J Neurooncol

Predmety: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Research, Disease Progression [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], TTF-1, Adenocarcinoma of Lung/surgery [MeSH], Survival, Male [MeSH], Brain Neoplasms/mortality [MeSH], Brain Metastasis, Ki67, Edema volume, LUAD, Female [MeSH], Lung Neoplasms/mortality [MeSH], Follow-Up Studies [MeSH], Brain Neoplasms/secondary [MeSH], Adult [MeSH], Humans [MeSH], Tumor volume, Retrospective Studies [MeSH], Middle Aged [MeSH], Adenocarcinoma of Lung/metabolism [MeSH], Survival Rate [MeSH], Biomarkers, Tumor/metabolism [MeSH], Adenocarcinoma of Lung/mortality [MeSH], Prognosis [MeSH], Lung Neoplasms/pathology [MeSH], Lung Neoplasms/metabolism [MeSH], Adenocarcinoma of Lung/pathology [MeSH], Brain Neoplasms/metabolism [MeSH], Thyroid Nuclear Factor 1/metabolism [MeSH]

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39630375
https://repository.publisso.de/resource/frl:6499899

Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis

Autori: Harald Krenzlin Dragan Jankovic Alice Dauth a ďalší

Prispievatelia: Harald Krenzlin Dragan Jankovic Alice Dauth a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Brain Neoplasms, Research, 610 Medizin, Female [MeSH], Follow-Up Studies [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Multimodal therapy, Retrospective Studies [MeSH], Middle Aged [MeSH], Glioblastoma/pathology [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], Neurosurgical Procedures [MeSH], Extent of resection, Survival Rate [MeSH], Multicentric, Glioblastoma/mortality [MeSH], Male [MeSH], Prognosis [MeSH], Brain Neoplasms/mortality [MeSH], Multifocal, Combined Modality Therapy [MeSH], Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Middle Aged, Prognosis, Combined Modality Therapy, Neurosurgical Procedures, ddc, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, 610 Medical sciences, Humans, Female, Retrospective Studies, Aged, Follow-Up Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39560695
https://repository.publisso.de/resource/frl:6501576
https://mediatum.ub.tum.de/doc/1770657/document.pdf

A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design

Autori: Wetzel, Ethan A. Nohman, Amin I. Hsieh, Annie L. a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Clinical Trials as Topic, Brain Neoplasms, Research, Glioma, Neoplasm Grading [MeSH], Aged [MeSH], Research Design [MeSH], Glioma/mortality [MeSH], Glioma/pathology [MeSH], Male [MeSH], Astrocytoma/genetics [MeSH], Brain Neoplasms/mortality [MeSH], Cyclin-Dependent Kinase Inhibitor p15/genetics [MeSH], Astrocytoma, Astrocytoma/mortality [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], Brain Neoplasms/genetics [MeSH], Adult [MeSH], Humans [MeSH], Astrocytoma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Isocitrate dehydrogenase (IDH), Cyclin-Dependent Kinase Inhibitor p16/genetics [MeSH], Survival Rate [MeSH], Glioma/diagnosis [MeSH], Clinical Trials as Topic [MeSH], Biomarkers, Tumor/genetics [MeSH], Glioma/genetics [MeSH], Prognosis [MeSH], Young Adult [MeSH], WHO grade 4, Isocitrate Dehydrogenase/genetics [MeSH], Brain Neoplasms/pathology [MeSH], Middle Aged, Prognosis, Isocitrate Dehydrogenase, Survival Rate, Research Design, Mutation, Humans, Female, Neoplasm Grading, Cyclin-Dependent Kinase Inhibitor p16, Retrospective Studies, Aged, Cyclin-Dependent Kinase Inhibitor p15, Follow-Up Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39432026
https://repository.publisso.de/resource/frl:6495852

In-patient neurosurgical tumor treatments for malignant glioma patients in Germany

Autori: Kamp, Marcel A. Fink, Larissa Forster, Marie-Therese a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Inpatients, Adolescent, Brain Neoplasms, Research, Glioma, Middle Aged, Neurosurgical Procedures, Glioma/surgery [MeSH], Aged [MeSH], Malignant glioma, Brain Neoplasms/surgery [MeSH], Postoperative Complications/epidemiology [MeSH], Glioma/mortality [MeSH], Hospital Mortality [MeSH], Germany/epidemiology [MeSH], Palliative care, Inpatients/statistics, Mortality, Male [MeSH], Brain Neoplasms/mortality [MeSH], Surgery, Glioma/therapy [MeSH], Adolescent [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Glioblastoma, Fluorescence-guided resection, Age, Young Adult [MeSH], Monitoring, Neurosurgical Procedures/mortality [MeSH], Young Adult, Postoperative Complications, Germany, Humans, Female, Hospital Mortality, Aged

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39390195
https://repository.publisso.de/resource/frl:6506032

Determinants of long-term survival in patients with IDH-mutant gliomas

Autori: Katzendobler, Sophie Niedermeyer, Sebastian Blobner, Jens a ďalší

Prispievatelia: Katzendobler, Sophie Niedermeyer, Sebastian Blobner, Jens a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Adolescent, Oligodendroglioma, 610 Medicine & health, Aged [MeSH], Glioma/mortality [MeSH], Glioma/pathology [MeSH], Male [MeSH], Astrocytoma/genetics [MeSH], Brain Neoplasms/mortality [MeSH], Case-Control Studies [MeSH], Astrocytoma, Astrocytoma/mortality [MeSH], Adolescent [MeSH], Female [MeSH], Oligodendroglioma/mortality [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], Brain Neoplasms/genetics [MeSH], Adult [MeSH], Humans [MeSH], Astrocytoma/pathology [MeSH], Oligodendroglioma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], IDH-mutation, Oligodendroglioma/genetics [MeSH], Survival Rate [MeSH], Lower grade glioma, Research, Glioma/genetics [MeSH], Prognosis [MeSH], Young Adult [MeSH], Chemotherapy, Temozolomide, Radiotherapy, Isocitrate Dehydrogenase/genetics [MeSH], Brain Neoplasms/pathology [MeSH], Young Adult, Humans, 1306 Cancer Research, Retrospective Studies, Aged, Brain Neoplasms, Glioma, Middle Aged, Prognosis, Isocitrate Dehydrogenase, 10040 Clinic for Neurology, Survival Rate, 2728 Neurology (clinical), 2808 Neurology, Case-Control Studies, Mutation, 2730 Oncology, Female, Follow-Up Studies

Popis súboru: s11060_024_04826_9.pdf - application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39316316
https://repository.publisso.de/resource/frl:6490810
https://epub.ub.uni-muenchen.de/126248/

Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients

Autori: Seyma Alcicek Ulrich Pilatus Andrei Manzhurtsev a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, 0301 basic medicine, Alanine, Magnetic Resonance Spectroscopy, Isocitrate Dehydrogenase/metabolism [MeSH], Aged [MeSH], Magnetic Resonance Spectroscopy/methods [MeSH], Gliomas, Amino acid metabolism, Magnetic resonance spectroscopy, Glioma/mortality [MeSH], Glioma/pathology [MeSH], Male [MeSH], Brain Neoplasms/mortality [MeSH], Amino Acids/metabolism [MeSH], Female [MeSH], Glioma/metabolism [MeSH], Mutation [MeSH], Adult [MeSH], Humans [MeSH], Inositol/metabolism [MeSH], Overall survival, Case Study, Middle Aged [MeSH], IDH mutation, Glioma/diagnosis [MeSH], Biomarkers, Tumor/metabolism [MeSH], Glioma/genetics [MeSH], Prognosis [MeSH], Young Adult [MeSH], Brain Neoplasms/diagnostic imaging [MeSH], Alanine/metabolism [MeSH], Brain Neoplasms/metabolism [MeSH], Isocitrate Dehydrogenase/genetics [MeSH], Brain Neoplasms/pathology [MeSH], Brain Neoplasms, Glioma, Middle Aged, Prognosis, Isocitrate Dehydrogenase, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Mutation, Biomarkers, Tumor, Humans, Female, Amino Acids, Inositol, Aged

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39192067
https://repository.publisso.de/resource/frl:6518148

Neurosurgical resection of multiple brain metastases: outcomes, complications, and survival rates in a retrospective analysis

Autori: Niedermeyer, Sebastian Schmutzer-Sondergeld, M. Weller, J. a ďalší

Zdroj: J Neurooncol

Predmety: Male, Brain Neoplasms, Female [MeSH], Follow-Up Studies [MeSH], Brain Neoplasms/secondary [MeSH], Survival rates, Aged [MeSH], Surgical resection, Humans [MeSH], Treatment Outcome [MeSH], Brain Neoplasms/surgery [MeSH], Postoperative Complications/epidemiology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Complications, Male [MeSH], Research, Prognosis [MeSH], Brain Neoplasms/mortality [MeSH], Multiple brain metastases, Neurosurgical Procedures/adverse effects [MeSH], Neurosurgical Procedures/mortality [MeSH], Middle Aged, Prognosis, Neurosurgical Procedures, Survival Rate, 03 medical and health sciences, Postoperative Complications, Treatment Outcome, 0302 clinical medicine, Humans, Female, Retrospective Studies, Aged, Follow-Up Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38904924
https://repository.publisso.de/resource/frl:6513104
https://epub.ub.uni-muenchen.de/126138/

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

Autori: Conrad, Katharina Löber-Handwerker, Ronja Hazaymeh, Mohammad a ďalší

Prispievatelia: Conrad, Katharina Löber-Handwerker, Ronja Hazaymeh, Mohammad a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Aged, 80 and over, Survival analysis, Aged, 80 and over [MeSH], Aged [MeSH], Risk Assessment [MeSH], Prognostic factors, Decision Trees [MeSH], Male [MeSH], Brain Neoplasms/mortality [MeSH], Brain Neoplasms/diagnosis [MeSH], Algorithms [MeSH], Glioblastoma/diagnosis [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], Survival Rate [MeSH], Glioblastoma/mortality [MeSH], Research, Prognosis [MeSH], Precision Medicine [MeSH], Brain Neoplasms/therapy [MeSH], Brain Neoplasms, Decision Trees, Middle Aged, Prognosis, Risk Assessment, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Humans, Female, Precision Medicine, Algorithms, Aged, Retrospective Studies, Follow-Up Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38639854
https://resolver.sub.uni-goettingen.de/purl?gro-2/143037
https://repository.publisso.de/resource/frl:6495537

Sarcopenia is associated with chemoradiotherapy discontinuation and reduced progression-free survival in glioblastoma patients

Autori: Fabian M. Troschel Benjamin O. Troschel Maren Kloss a ďalší

Zdroj: Strahlenther Onkol

Predmety: Male, Sarcopenia, Brain Neoplasms, Radiotherapy Planning, Computer-Assisted, Chemoradiotherapy, Middle Aged, Progression-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Sarcopenia/etiology [MeSH], Disease Progression [MeSH], Aged [MeSH], Progression-Free Survival [MeSH], Radiation therapy, Palliative care, Original Article, Tomography, X-Ray Computed [MeSH], Glioblastoma/radiotherapy [MeSH], Male [MeSH], Radiation Dose Hypofractionation [MeSH], Frailty, Brain Neoplasms/mortality [MeSH], Withholding Treatment [MeSH], Female [MeSH], Brain Neoplasms/radiotherapy [MeSH], Computed tomography, Radiotherapy Planning, Computer-Assisted [MeSH], Humans [MeSH], Prognostic biomarker, Retrospective Studies [MeSH], Middle Aged [MeSH], Glioblastoma/therapy [MeSH], Glioblastoma/mortality [MeSH], Body composition, Chemoradiotherapy [MeSH], Brain Neoplasms/therapy [MeSH], Withholding Treatment, Disease Progression, Humans, Female, Radiation Dose Hypofractionation, Glioblastoma, Tomography, X-Ray Computed, Aged, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38546749
https://repository.publisso.de/resource/frl:6508739

Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers

Autori: Christoph Straube Stephanie E. Combs Denise Bernhardt a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Brain Neoplasms, Research, Tumor Suppressor Proteins, Middle Aged, ddc, Re-Irradiation, Cohort Studies, Tertiary Care Centers, 03 medical and health sciences, DNA Repair Enzymes, 0302 clinical medicine, Glioblastoma, Recurrence, Re-irradiation, 2nd surgery, GTR, Gross total resection, Adjuvant radiotherapy, Cohort study, Humans, Female, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, Tumor Suppressor Proteins/genetics [MeSH], Aged [MeSH], Tertiary Care Centers [MeSH], Brain Neoplasms/surgery [MeSH], DNA Modification Methylases/metabolism [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Cohort Studies [MeSH], Tumor Suppressor Proteins/metabolism [MeSH], Glioblastoma/radiotherapy [MeSH], DNA Repair Enzymes/metabolism [MeSH], Male [MeSH], Brain Neoplasms/mortality [MeSH], Radiotherapy, Adjuvant [MeSH], Female [MeSH], Brain Neoplasms/radiotherapy [MeSH], Adult [MeSH], Glioblastoma/surgery [MeSH], Humans [MeSH], DNA Repair Enzymes/genetics [MeSH], Middle Aged [MeSH], DNA Modification Methylases/genetics [MeSH], Glioblastoma/mortality [MeSH], Re-Irradiation/methods [MeSH], DNA Modification Methylases, Aged

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38520571
https://repository.publisso.de/resource/frl:6508440
https://mediatum.ub.tum.de/doc/1770658/document.pdf

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

Autori: Kerstin Hofstetter Julian Taugner Lukas Käsmann a ďalší

Zdroj: Strahlenther Onkol

Predmety: Male, Aged, 80 and over, Adult, Lung Neoplasms, Aged, 80 and over [MeSH], Aged [MeSH], Metastasis, Original Article, Neoplasm Staging [MeSH], Carcinoma, Non-Small-Cell Lung/mortality [MeSH], Male [MeSH], Brain Neoplasms/mortality [MeSH], Thoracic Radiotherapy, Carcinoma, Non-Small-Cell Lung/pathology [MeSH], Female [MeSH], Outcome, Lung Neoplasms/mortality [MeSH], Brain Neoplasms/secondary [MeSH], Lung Neoplasms/therapy [MeSH], Adult [MeSH], Lung Cancer, Humans [MeSH], Neoplasm Metastasis [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Lung Neoplasms/pathology [MeSH], Immune Checkpoint Inhibition, Carcinoma, Non-Small-Cell Lung/therapy [MeSH], Chemoradiotherapy [MeSH], Brain Neoplasms/therapy [MeSH], Brain Neoplasms, Chemoradiotherapy, Middle Aged, 3. Good health, Carcinoma, Non-Small-Cell Lung, Humans, Female, Neoplasm Metastasis, Immune Checkpoint Inhibitors, Aged, Retrospective Studies, Neoplasm Staging

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37975883
https://repository.publisso.de/resource/frl:6524394
https://epub.ub.uni-muenchen.de/116266/

Impact of levetiracetam use in glioblastoma: an individual patient-level meta-analysis assessing overall survival

Autori: Vychopen, Martin Güresir, Agi Basaran, Alim Emre a ďalší

Zdroj: Neurosurg Rev

Predmety: 0301 basic medicine, Anti-epileptic drug, Humans [MeSH], Overall survival, Levetiracetam, Glioblastoma, Glioblastoma/drug therapy [MeSH], Individual Patient Data, Anticonvulsants/therapeutic use [MeSH], Glioblastoma/mortality [MeSH], Brain Neoplasms/mortality [MeSH], Review, Levetiracetam/therapeutic use [MeSH], Brain Neoplasms/drug therapy [MeSH], 0303 health sciences, 03 medical and health sciences, Brain Neoplasms, Humans, Anticonvulsants

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39653818
https://repository.publisso.de/resource/frl:6519213

Influence of brain metastases on the classification, treatment, and outcome of patients with extracranial oligometastasis: a single-center cross-sectional analysis

Autori: Christ, Sebastian M Thiel, Gabriel W Heesen, Philip a ďalší

Prispievatelia: Christ, Sebastian M Thiel, Gabriel W Heesen, Philip a ďalší

Zdroj: Radiat Oncol
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)

Predmety: Male, Adult, Research, Oligometastasis, Brain metastasis, Treatment paradigms, R895-920, 610 Medicine & health, Medical physics. Medical radiology. Nuclear medicine, 2741 Radiology, Nuclear Medicine and Imaging, Humans, RC254-282, Aged, Retrospective Studies, Aged, 80 and over, Brain Neoplasms, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 10181 Clinic for Nuclear Medicine, Middle Aged, Prognosis, 10044 Clinic for Radiation Oncology, Female [MeSH], Brain Neoplasms/radiotherapy [MeSH], Aged, 80 and over [MeSH], Brain Neoplasms/secondary [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Cross-Sectional Studies [MeSH], Survival Rate [MeSH], Magnetic Resonance Imaging [MeSH], Male [MeSH], Prognosis [MeSH], Positron-Emission Tomography [MeSH], Brain Neoplasms/mortality [MeSH], Brain Neoplasms/therapy [MeSH], Magnetic Resonance Imaging, 10040 Clinic for Neurology, ddc, Survival Rate, Cross-Sectional Studies, Positron-Emission Tomography, 2730 Oncology, Female

Popis súboru: application/pdf; ZORA265499.pdf - application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39465396
https://doaj.org/article/ff7a943679364d83a351928248cf211e
https://repository.publisso.de/resource/frl:6496404
https://mediatum.ub.tum.de/doc/1770422/document.pdf
https://www.zora.uzh.ch/id/eprint/265499/
https://doi.org/10.5167/uzh-265499

Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study: study protocol for a randomized phase III study

Autori: Preusser, Matthias Kazda, Tomáš Le Rhun, Emilie a ďalší

Prispievatelia: Preusser, Matthias Kazda, Tomáš Le Rhun, Emilie a ďalší

Zdroj: Trials
Trials, Vol 25, Iss 1, Pp 1-10 (2024)

Predmety: Medicine (General), Time Factors, 610 Medicine & health, Study Protocol, R5-920, Disease Progression [MeSH], Randomized controlled trial, Progression-Free Survival [MeSH], Antineoplastic Agents, Alkylating/therapeutic use [MeSH], Glioblastoma/pathology [MeSH], Reirradiation, Clinical Trials, Phase III as Topic [MeSH], Glioblastoma/drug therapy [MeSH], Randomized Controlled Trials as Topic [MeSH], Glioblastoma/radiotherapy [MeSH], Quality of Life [MeSH], Lomustine/adverse effects [MeSH], Brain Neoplasms/mortality [MeSH], Lomustine/administration, Lomustine, Brain Neoplasms/radiotherapy [MeSH], Humans [MeSH], Pragmatic Clinical Trials as Topic [MeSH], Chemoradiotherapy/methods [MeSH], Progression, Multicenter Studies as Topic [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], LEGATO, Time Factors [MeSH], Lomustine/therapeutic use [MeSH], Glioblastoma/mortality [MeSH], Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Pragmatic Clinical Trials as Topic, Humans, Multicenter Studies as Topic, Antineoplastic Agents, Alkylating, Randomized Controlled Trials as Topic, Brain Neoplasms, Chemoradiotherapy, Progression-Free Survival, 10040 Clinic for Neurology, 3. Good health, Clinical Trials, Phase III as Topic, 10032 Clinic for Oncology and Hematology, Disease Progression, Quality of Life

Popis súboru: application/pdf; s13063_024_08213_7.pdf - application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38849943
https://doaj.org/article/da487c7b1214453fb930ea4fb6b04a3a
https://hdl.handle.net/1887/4209080
https://repository.publisso.de/resource/frl:6505004
https://www.zora.uzh.ch/id/eprint/260249/
https://doi.org/10.5167/uzh-260249

Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA

Autori: C. Posch Christian Diehl Bernhard Meyer a ďalší

Zdroj: Clin Transl Oncol
Clin. Transl. Oncol. 23, 2020-2029 (2021)

Predmety: Adult, Aged, 80 and over, Male, Proto-Oncogene Proteins B-raf, Brain Neoplasms, Aged, 80 and over [MeSH], Melanoma, Aged [MeSH], Proto-Oncogene Proteins B-raf/genetics [MeSH], GPA, Radiosurgery, Prognostic factors, Radiosurgery/methods [MeSH], Radiosurgery/adverse effects [MeSH], Brain metastases, Melanoma/diagnostic imaging [MeSH], Male [MeSH], Brain Neoplasms/mortality [MeSH], Research Article, Karnofsky Performance Status [MeSH], Female [MeSH], Brain Neoplasms/radiotherapy [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], Brain Neoplasms/secondary [MeSH], Adult [MeSH], Humans [MeSH], Melanoma/secondary [MeSH], Treatment Outcome [MeSH], Melanoma/radiotherapy [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Melanoma/mortality [MeSH], SRS, Prognosis [MeSH], Radiotherapy Dosage [MeSH], Brain Neoplasms/diagnostic imaging [MeSH], Radiotherapy Dosage, Middle Aged, Prognosis, ddc, Brain Metastases, Gpa, Prognostic Factors, Srs, 3. Good health, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Mutation, Humans, Female, Karnofsky Performance Status, Aged, Follow-Up Studies, Retrospective Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s12094-021-02607-8.pdf
https://pubmed.ncbi.nlm.nih.gov/33993415
https://link.springer.com/article/10.1007/s12094-021-02607-8
https://pubmed.ncbi.nlm.nih.gov/33993415/
https://dialnet.unirioja.es/servlet/articulo?codigo=8062060
https://link.springer.com/content/pdf/10.1007/s12094-021-02607-8.pdf
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=62109
https://repository.publisso.de/resource/frl:6445606
https://mediatum.ub.tum.de/doc/1624398/document.pdf

Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries

Autori: Ljupcho Efremov Semaw Ferede Abera Ahmed Bedir a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: Adult, Aged, 80 and over, Male, ddc:610, Adolescent, Brain Neoplasms, Original Article – Clinical Oncology, Age Factors, Middle Aged, 3. Good health, Survival Rate, Young Adult, Germany, Age Factors [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Germany/epidemiology [MeSH], Glioblastoma/drug therapy [MeSH], Proportional Hazards Models [MeSH], Male [MeSH], Antineoplastic Agents, Alkylating/administration, Brain Neoplasms/mortality [MeSH], Cancer registry, Adolescent [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Overall survival, Middle Aged [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], Survival Rate [MeSH], Glioblastoma/mortality [MeSH], Young Adult [MeSH], Temozolomide/administration, Brain Neoplasms/drug therapy [MeSH], Temozolomide, Registries [MeSH], Brain Neoplasms/therapy [MeSH], Humans, Female, Registries, 10. No inequality, Antineoplastic Agents, Alkylating, Aged, Proportional Hazards Models

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00432-021-03596-5.pdf
https://pubmed.ncbi.nlm.nih.gov/33743072
https://pubmed.ncbi.nlm.nih.gov/33743072/
https://link.springer.com/content/pdf/10.1007/s00432-021-03596-5.pdf
https://link.springer.com/article/10.1007/s00432-021-03596-5
https://www.ncbi.nlm.nih.gov/pubmed/33743072
https://europepmc.org/article/MED/33743072
https://repository.publisso.de/resource/frl:6449908

Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide

Autori: Kerstin Berger Bernd Turowski Jörg Felsberg a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: Adult, Male, Original Article – Clinical Oncology, Maintenance Chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Biomarkers, Tumor, Humans, Antineoplastic Agents, Alkylating, Aged, Retrospective Studies, Aged, 80 and over, Brain Neoplasms, Age Factors, Chemoradiotherapy, Middle Aged, Prognosis, Combined Modality Therapy, Isocitrate Dehydrogenase, 3. Good health, Age Factors [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Chemoradiotherapy/mortality [MeSH], Maintenance Chemotherapy/mortality [MeSH], Antineoplastic Agents, Alkylating/therapeutic use [MeSH], Glioblastoma/pathology [MeSH], Survival, Male [MeSH], Brain Neoplasms/mortality [MeSH], Combined Modality Therapy [MeSH], Glioblastoma/genetics [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], Age at diagnosis, Brain Neoplasms/genetics [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], Survival Rate [MeSH], Glioblastoma/mortality [MeSH], Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], Young Adult [MeSH], Temozolomide/therapeutic use [MeSH], Isocitrate Dehydrogenase/genetics [MeSH], Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Mutation, Female, Follow-Up Studies

Popis súboru: pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00432-020-03334-3.pdf
https://pubmed.ncbi.nlm.nih.gov/32748120
https://link.springer.com/article/10.1007/s00432-020-03334-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810639
https://link.springer.com/content/pdf/10.1007/s00432-020-03334-3.pdf
https://pubmed.ncbi.nlm.nih.gov/32748120/
https://europepmc.org/article/PMC/PMC7810639
https://repository.publisso.de/resource/frl:6469376

EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma

Autori: Nina Struve Zev A. Binder Lucy F. Stead a ďalší

Zdroj: Oncogene

Predmety: 0301 basic medicine, MAP Kinase Signaling System, Kaplan-Meier Estimate, DNA Mismatch Repair, Article, Cohort Studies, Mice, 03 medical and health sciences, 0302 clinical medicine, Gene Expression Regulation, Neoplastic [MeSH], Cell Line, Tumor [MeSH], Tumor Suppressor Proteins/genetics [MeSH], DNA Modification Methylases/metabolism [MeSH], Up-Regulation [MeSH], DNA-Binding Proteins/genetics [MeSH], Cohort Studies [MeSH], ErbB Receptors/metabolism [MeSH], Tumor Suppressor Proteins/metabolism [MeSH], DNA Repair Enzymes/metabolism [MeSH], Cell signalling, Xenograft Model Antitumor Assays [MeSH], Drug Resistance, Neoplasm/genetics [MeSH], MutS Homolog 2 Protein/genetics [MeSH], Brain Neoplasms/mortality [MeSH], Glioblastoma/genetics [MeSH], Temozolomide/pharmacology [MeSH], Female [MeSH], Mutation [MeSH], Brain Neoplasms/genetics [MeSH], Kaplan-Meier Estimate [MeSH], Humans [MeSH], Gene Knockdown Techniques [MeSH], Chemoradiotherapy/methods [MeSH], DNA Repair Enzymes/genetics [MeSH], CNS cancer, ErbB Receptors/genetics [MeSH], Retrospective Studies [MeSH], DNA Mismatch Repair/drug effects [MeSH], Animals [MeSH], DNA Mismatch Repair/genetics [MeSH], Glioblastoma/therapy [MeSH], DNA Modification Methylases/genetics [MeSH], Promoter Regions, Genetic/genetics [MeSH], Mice [MeSH], Glioblastoma/mortality [MeSH], MAP Kinase Signaling System/genetics [MeSH], DNA Methylation [MeSH], DNA mismatch repair, Temozolomide/therapeutic use [MeSH], Brain Neoplasms/therapy [MeSH], Cell Line, Tumor, Animals, Humans, DNA Modification Methylases, Brain Neoplasms, Chemoradiotherapy, DNA Methylation, 3. Good health, DNA-Binding Proteins, ErbB Receptors, Gene Expression Regulation, Neoplastic, DNA Repair Enzymes, Drug Resistance, Neoplasm, Gene Knockdown Techniques, Female, Glioblastoma

Popis súboru: application/pdf

Prístupová URL adresa: https://www.nature.com/articles/s41388-020-1208-5.pdf
https://pubmed.ncbi.nlm.nih.gov/32066879
https://www.nature.com/articles/s41388-020-1208-5
https://eprints.whiterose.ac.uk/160803/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142016
https://fis-uke.de/portal/de/publications/egfrviii-upregulates-dna-mismatch-repair-resulting-in-increased-temozolomide-sensitivity-of-mgmt-promoter-methylated-glioblastoma(f9b8f5c7-4f5e-4c86-a73e-06af017a7e3b).html
https://research-information.bris.ac.uk/en/publications/egfrviii-upregulates-dna-mismatch-repair-resulting-in-increased-t
https://www.ncbi.nlm.nih.gov/pubmed/32066879
https://repository.publisso.de/resource/frl:6471354

Multifocal high-grade glioma radiotherapy safety and efficacy

Autori: Niklas Thon Claus Belka D.F. Fleischmann a ďalší

Zdroj: Radiat Oncol
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)

Predmety: Adult, Aged, 80 and over, Male, Multifocal high-grade glioma, Efficacy, Radiotherapy, Brain Neoplasms, Research, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Chemoradiotherapy, Glioma, Middle Aged, 3. Good health, Medical physics. Medical radiology. Nuclear medicine, 03 medical and health sciences, Female [MeSH], Brain Neoplasms/radiotherapy [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Clinical Radiation Oncology, Middle Aged [MeSH], Safety, Glioma/mortality [MeSH], Glioma/radiotherapy [MeSH], Glioma/drug therapy [MeSH], Male [MeSH], Radiotherapy/adverse effects [MeSH], Brain Neoplasms/mortality [MeSH], Dose Fractionation, Radiation [MeSH], Brain Neoplasms/drug therapy [MeSH], Chemoradiotherapy [MeSH], 0302 clinical medicine, Humans, Female, Dose Fractionation, Radiation, RC254-282, Aged, Retrospective Studies

Prístupová URL adresa: https://ro-journal.biomedcentral.com/track/pdf/10.1186/s13014-021-01886-3
https://pubmed.ncbi.nlm.nih.gov/34454558
https://doaj.org/article/99491f3bfc484554b448688885e24536
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400399
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-021-01886-3
https://europepmc.org/article/MED/34454558
https://link.springer.com/content/pdf/10.1186/s13014-021-01886-3.pdf
https://pubmed.ncbi.nlm.nih.gov/34454558/
https://paperity.org/p/269490856/multifocal-high-grade-glioma-radiotherapy-safety-and-efficacy
https://repository.publisso.de/resource/frl:6463453
https://epub.ub.uni-muenchen.de/90934/

WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer

Autori: Menck, Kerstin Heinrichs, Saskia Wlochowitz, Darius a ďalší

Zdroj: http://lobid.org/resources/99370679188706441#!, 40(1):395.

Predmety: Wnt Signaling Pathway/genetics [MeSH], Brain Neoplasms/genetics [MeSH], Humans [MeSH], Metastasis, Neoplasm Metastasis [MeSH], BRCAness, Breast cancer, Survival Analysis [MeSH], Neoplasm Invasiveness [MeSH], Network analysis, ROR2, Transfection [MeSH], Research, Brain Neoplasms/mortality [MeSH], WNT11

Relation: https://repository.publisso.de/resource/frl:6443364; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672621/

Dostupnosť: https://repository.publisso.de/resource/frl:6443364
https://doi.org/10.1186/s13046-021-02187-z
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672621/